| Visualizaciones | |
|---|---|
| Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical | 519 |
| diciembre 2025 | enero 2026 | febrero 2026 | marzo 2026 | abril 2026 | mayo 2026 | junio 2026 | |
|---|---|---|---|---|---|---|---|
| Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical | 1 | 10 | 4 | 12 | 29 | 30 | 8 |
| Visualizaciones | |
|---|---|
| 34-2017 Journal of Radioanalytical and Nuclear Chemistry-Alondra-1.pdf | 489 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 173 |
| México | 60 |
| Alemania | 52 |
| Canadá | 31 |
| China | 22 |
| Rusia | 20 |
| Japón | 19 |
| Paquistán | 15 |
| Ucrania | 13 |
| Austria | 11 |
| Visualizaciones | |
|---|---|
| Kiez | 49 |
| Ottawa | 27 |
| Woodbridge | 24 |
| Fairfield | 19 |
| Gulberg | 15 |
| Houston | 14 |
| Mexico | 13 |
| Cambridge | 12 |
| Dearborn | 11 |
| Jacksonville | 11 |